CTA
MRK icon

Clear Trail Advisors’s Merck MRK Stock Holding History

Clear Trail Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.12M Buy
71,003
+303
+0.4% +$35.5K 1.39% 23
2026
Q1 		$8.5M Sell
70,700
-4,971
-7% -$574K 1.42% 24
2025
Q4 		$7.97M Buy
+75,671
New +$7.1M 1.85% 16

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Clear Trail Advisors's MRK Position: Q2 2026 in Review

Clear Trail Advisors increased its Merck (MRK) stake by 0.43% in Q2 2026, buying an estimated $35.5K and bringing the position to 71,003 shares worth $9.12M. The position accounts for 1.39% of the portfolio, ranked #23.

Clear Trail Advisors first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 3,815 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Clear Trail Advisors held 71,003 shares of Merck worth $9.12M as of Q2 2026.
  • Clear Trail Advisors bought 303 Merck shares in Q2 2026, an estimated $35.5K.
  • Merck made up 1.39% of Clear Trail Advisors's portfolio in Q2 2026, its #23 holding.
  • Clear Trail Advisors first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • 3,815 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Clear Trail Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.